|
|
| | ||
|
|
|
| Catalog No. | Product Name | CAS No. |
| AXT01 | Axitinib ["AG-013736"] | 319460-85-0 |
| BST01 | Bosutinib | 380843-75-4 |
| BVN01 | Brivanib Alaninate | 649735-63-7 |
| CPT01 | Camptothecin | 7689-03-4 |
| CNT01 | Canertinib Dihydrochloride | 289499-45-2 |
| CDR01 | Cediranib | 288383-20-0 |
| CPT01 | Dasatinib | 302962-49-8 |
| DCT01 | Decitabine | 2353-33-5 |
| DVT01 | Dovitinib | 915769-50-5 |
| EPT01 | Epothilone A | 152044-53-6 |
| EPT02 | Epothilone B | 152044-54-7 |
| ELT02 | Erlotinib HCl | 183319-69-9 |
| CPT02 | 7-Ethyl Camptothecin | 64439-81-2 |
| CPT03 | 7-Ethyl-10-Hydroxy Camptothecin | 64439-81-2 |
| GFT01 | Gefitinib | 184475-35-2 |
| GDM01 | Geldanamycin | 30562-34-6 |
| GCT01 | Gemcitabine HCl | 122111-03-9 |
| CPT04 | 10-Hydroxy Camptothecin | 19685-09-7 |
| MTT07 | 7-Hydroxy Methotrexate | ? |
| IMT01 | Imatinib Mesylate | 220127-57-1 |
| CPT05 | Irinotecan HCl Trihydrate | 136572-09-3 |
| LPT01 | Lapatinib | 231277-92-2 |
| LST01 | Lestaurtinib | 111358-88-4 |
| MTS01 | Motesanib Diphosphate | 857876-30-3 |
| NLT01 | Nilotinib | 641571-10-0 |
| PZP01 | Pazopanib | 444731-52-6 |
| PTS01 | Pentostatin | 53910-25-1 |
| RBC01 | Rebeccamycin | 93908-02-2 |
| SRF01 | Sorafenib Tosylate | 475207-59-1 |
| SNT01 | Sunitinib Malate | 341031-54-7 |
| TDT01 | Tandutinib | 387867-13-2 |
| TSL01 | Temsirolimus | 162635-04-3 |
| CPT06 | Topotecan | 123948-87-8 |
| VDT01 | Vandetanib | 443913-73-3 |
|
Patented products are only available for R&D use as permitted under CFR 35 Section 271(e)(1). Copyright © 2005 All Rights Reserved. MOLCAN CORPORATION, Canada, Tel. 905-731-5537, Fax 905-248-3843, E-Mail: contact@molcan.com |